(Q38300355)

1 September 2017

1 reference

title

In the grey zone between epilepsy and schizophrenia: alterations in group II metabotropic glutamate receptors (English)

1 reference

1 September 2017

1 reference

Stefanie Dedeurwaerdere

1

1 reference

1 September 2017

Stephanie Boets

2

1 reference

1 September 2017

Pieter Janssens

3

1 reference

1 September 2017

Hilde Lavreysen

4

1 reference

1 September 2017

Thomas Steckler

5

1 reference

1 September 2017

publication date

25 December 2014

1 reference

1 September 2017

published in

Acta Neurologica Belgica

1 reference

1 September 2017

volume

115

1 reference

1 September 2017

issue

3

1 reference

1 September 2017

page(s)

221-232

1 reference

https://scigraph.springernature.com/pub.10.1007/s13760-014-0407-7

1 September 2017

exact match

0 references

cites work

Metabotropic glutamate receptors as a strategic target for the treatment of epilepsy

1 reference

https://api.crossref.org/works/10.1007%2FS13760-014-0407-7

Anticonvulsant and glutamate release-inhibiting properties of the highly potent metabotropic glutamate receptor agonist (2S,2'R, 3'R)-2-(2',3'-dicarboxycyclopropyl)glycine (DCG-IV).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13760-014-0407-7

Key factors in the discovery and development of new antiepileptic drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13760-014-0407-7

International consensus classification of hippocampal sclerosis in temporal lobe epilepsy: a Task Force report from the ILAE Commission on Diagnostic Methods

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13760-014-0407-7

Epidemiology and natural history of schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13760-014-0407-7

Exposure to prenatal infection and risk of schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13760-014-0407-7

Regulation of neurotransmitter release by metabotropic glutamate receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13760-014-0407-7

Schizophrenia and epilepsy: is there a shared susceptibility?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13760-014-0407-7

Group II metabotropic glutamate receptor agonists as a potential drug for schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13760-014-0407-7

Bidirectional relation between schizophrenia and epilepsy: a population-based retrospective cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13760-014-0407-7

A case-control study of the relationship between the metabotropic glutamate receptor 3 gene and schizophrenia in the Chinese population

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13760-014-0407-7

Genetic association studies of glutamate, GABA and related genes in schizophrenia and bipolar disorder: a decade of advance.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13760-014-0407-7

Promise of mGluR2/3 activators in psychiatry

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13760-014-0407-7

Activation of metabotropic glutamate receptors as a novel approach for the treatment of schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13760-014-0407-7

Comparative analysis of group II metabotropic glutamate receptor immunoreactivity in Brodmann's area 46 of the dorsolateral prefrontal cortex from patients with schizophrenia and normal subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13760-014-0407-7

Antibodies to the N-methyl-D-aspartate receptor and other synaptic proteins in psychosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13760-014-0407-7

PET imaging of brain inflammation during early epileptogenesis in a rat model of temporal lobe epilepsy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13760-014-0407-7

Manganese-enhanced MRI reflects seizure outcome in a model for mesial temporal lobe epilepsy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13760-014-0407-7

Memantine-induced brain activation as a model for the rapid screening of potential novel antipsychotic compounds: exemplified by activity of an mGlu2/3 receptor agonist.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13760-014-0407-7

Differential effects of clozapine and haloperidol on ketamine-induced brain metabolic activation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13760-014-0407-7

Extracellular hippocampal glutamate and spontaneous seizure in the conscious human brain.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13760-014-0407-7

Variation in GRM3 affects cognition, prefrontal glutamate, and risk for schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13760-014-0407-7

Differential changes in mGlu2 and mGlu3 gene expression following pilocarpine-induced status epilepticus: a comparative real-time PCR analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13760-014-0407-7

Activation of metabotropic glutamate (mGlu)2 receptors suppresses histamine release in limbic brain regions following acute ketamine challenge

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13760-014-0407-7

Group II metabotropic glutamate receptor agonists and positive allosteric modulators as novel treatments for schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13760-014-0407-7

Psychosis and temporal lobe epilepsy. A controlled investigation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13760-014-0407-7

Density of metabotropic glutamate receptors 2 and 3 (mGluR2/3) in the dorsolateral prefrontal cortex does not differ with schizophrenia diagnosis but decreases with age.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13760-014-0407-7

CNTNAP2 gene dosage variation is associated with schizophrenia and epilepsy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13760-014-0407-7

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13760-014-0407-7

Impaired expression and function of group II metabotropic glutamate receptors in pilocarpine-treated chronically epileptic rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13760-014-0407-7

Metabotropic glutamate receptor 2 and 3 gene expression in the human prefrontal cortex and mesencephalon in schizophrenia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13760-014-0407-7

Differential expression of metabotropic glutamate receptors 2 and 3 in schizophrenia: a mechanism for antipsychotic drug action?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13760-014-0407-7

Identification of a serotonin/glutamate receptor complex implicated in psychosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13760-014-0407-7

Metabotropic glutamate receptor protein expression in the prefrontal cortex and striatum in schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13760-014-0407-7

Prenatal stress induces schizophrenia-like alterations of serotonin 2A and metabotropic glutamate 2 receptors in the adult offspring: role of maternal immune system

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13760-014-0407-7

Seizure-induced neuronal injury: animal data

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13760-014-0407-7

Seizures and schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13760-014-0407-7

The neuropsychopharmacology of phencyclidine: from NMDA receptor hypofunction to the dopamine hypothesis of schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13760-014-0407-7

Structure and polymorphisms of the human metabotropic glutamate receptor type 2 gene (GRM2): analysis of association with schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13760-014-0407-7

Psychiatric comorbidities in temporal lobe epilepsy: possible relationships between psychotic disorders and involvement of limbic circuits.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13760-014-0407-7

A multicenter, inpatient, phase 2, double-blind, placebo-controlled dose-ranging study of LY2140023 monohydrate in patients with DSM-IV schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13760-014-0407-7

Molecular aspects of glutamate dysregulation: implications for schizophrenia and its treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13760-014-0407-7

The possible involvement of metabotropic glutamate receptors in schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13760-014-0407-7

HDAC2 regulates atypical antipsychotic responses through the modulation of mGlu2 promoter activity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13760-014-0407-7

Pharmacological characterization of JNJ-40068782, a new potent, selective, and systemically active positive allosteric modulator of the mGlu2 receptor and its radioligand [3H]JNJ-40068782.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13760-014-0407-7

Glutamate in schizophrenia: a focused review and meta-analysis of ¹H-MRS studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13760-014-0407-7

Metabotropic glutamate receptor mGluR2/3 and mGluR5 binding in the anterior cingulate cortex in psychotic and nonpsychotic depression, bipolar disorder and schizophrenia: implications for novel mGluR-based therapeutics

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13760-014-0407-7

In-vivo rodent models for the experimental investigation of prenatal immune activation effects in neurodevelopmental brain disorders.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13760-014-0407-7

Anticonvulsive and neuroprotective actions of a potent agonist (DCG-IV) for group II metabotropic glutamate receptors against intraventricular kainate in the rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13760-014-0407-7

Targeting metabotropic glutamate receptors for treatment of the cognitive symptoms of schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13760-014-0407-7

Glutamate metabotropic receptors as targets for drug therapy in epilepsy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13760-014-0407-7

Group II metabotropic glutamate receptors and schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13760-014-0407-7

Maternal influenza viral infection causes schizophrenia-like alterations of 5-HT₂A and mGlu₂ receptors in the adult offspring

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13760-014-0407-7

Cellular localization of mGluR3 and mGluR5 mRNAs in normal and injured rat brain.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13760-014-0407-7

Evaluation of 5-HT2A and mGlu2/3 receptors in postmortem prefrontal cortex of subjects with major depressive disorder: effect of antidepressant treatment.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13760-014-0407-7

Psychosis in epilepsy patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13760-014-0407-7

Metabotropic glutamate receptors: physiology, pharmacology, and disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13760-014-0407-7

Distribution of a metabotropic glutamate receptor, mGluR2, in the central nervous system of the rat and mouse: an immunohistochemical study with a monoclonal antibody.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13760-014-0407-7

Distribution of the messenger RNA for a metabotropic glutamate receptor, mGluR2, in the central nervous system of the rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13760-014-0407-7

Abnormal mGluR2/3 expression in the perforant path termination zones and mossy fibers of chronically epileptic rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13760-014-0407-7

Activation of mGlu2/3 receptors as a new approach to treat schizophrenia: a randomized Phase 2 clinical trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13760-014-0407-7

The role of glutamate in central nervous system health and disease--a review

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13760-014-0407-7

Risk for schizophrenia and schizophrenia-like psychosis among patients with epilepsy: population based cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13760-014-0407-7

Glutamate receptor function in learning and memory

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13760-014-0407-7

A "mock up" of schizophrenia: temporal lobe epilepsy and schizophrenia-like psychosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13760-014-0407-7

Upregulation of presynaptic mGluR2, but not mGluR3 in the epileptic medial perforant path.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13760-014-0407-7

Schizophrenia-like psychosis and epilepsy: the status of the association.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13760-014-0407-7

The schizophrenialike psychoses of epilepsy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13760-014-0407-7

Systemic injection of kainic acid differently affects LTP magnitude depending on its epileptogenic efficiency

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13760-014-0407-7

Metabotropic glutamate receptors as novel targets for anxiety and stress disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13760-014-0407-7

Metabotropic glutamate receptor 2/3 in the hippocampus of patients with mesial temporal lobe epilepsy, and of rats and mice after pilocarpine-induced status epilepticus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13760-014-0407-7

Expression of the group II and III metabotropic glutamate receptors in the hippocampus of patients with mesial temporal lobe epilepsy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13760-014-0407-7

Glutamate and glutamine measured with 4.0 T proton MRS in never-treated patients with schizophrenia and healthy volunteers

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13760-014-0407-7

Glutamate and glutamine in the anterior cingulate and thalamus of medicated patients with chronic schizophrenia and healthy comparison subjects measured with 4.0-T proton MRS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13760-014-0407-7

Progress in the developement of positive allosteric modulators of the metabotropic glutamate receptor 2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13760-014-0407-7

Hypolocomotive behaviour associated with increased microglia in a prenatal immune activation model with relevance to schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13760-014-0407-7

Classical neurotransmitters and neuropeptides involved in generalized epilepsy: a focus on antiepileptic drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13760-014-0407-7

Metabotropic glutamate receptors in the tripartite synapse as a target for new psychotropic drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13760-014-0407-7

Coexistence of schizophrenia and epilepsy: record-linkage studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13760-014-0407-7

CNS distribution of metabotropic glutamate 2 and 3 receptors: transgenic mice and [³H]LY459477 autoradiography

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13760-014-0407-7

10.1007/S13760-014-0407-7

21 January 2018

Identifiers

DOI

1 reference

1 September 2017

1 reference